Supernus Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Supernus Pharmaceuticals, Inc.

Oct-21	Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 SUPN GlobeNewswire
Aug-27	Supernus Pharmaceuticals to Participate in September Investor Conferences SUPN GlobeNewswire
Aug-05	Supernus Announces Second Quarter 2025 Financial Results SUPN GlobeNewswire
Jul-31	Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics SUPN GlobeNewswire
Jul-28	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer SUPN GlobeNewswire
Jul-22	Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025 SUPN GlobeNewswire
May-29	Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree Content Series with Supernus Pharmaceuticals SUPN GlobeNewswire
May-28	Supernus to Participate in the 2025 Jefferies Global Healthcare Conference SUPN GlobeNewswire
May-28	Supernus Announces Paragraph IV ANDA Filings for Qelbree SUPN GlobeNewswire
May-20	Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being 'Ms. Represented' in First-of-its-Kind Campaign with Supernus Pharmaceuticals SUPN GlobeNewswire
May-06	Supernus Announces First Quarter 2025 Financial Results SUPN GlobeNewswire